There were five systemic DLBCL samples of the patients who subsequently developed CNS involvement, but all were negative for Tim‐1 while three were positive for IL‐10, and it was suggested that secondary CNS involvement of systemic DLBCL is not associated with Tim‐1 expression of the primary lesions. The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.